Podiatrists in Laurel, MS Accepting Medicare

2 Podiatrists found. Showing 1 - 2

Dr. Michael S. Zaleski Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 528 N 15th Ave, Ste. E, Laurel, MS 39440 Phone: 601-268-0400    Fax: 601-264-3150

South Central Podiatry Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1002 Jefferson St, Suite 400, Laurel, MS 39440 Phone: 601-426-4010    Fax: 601-426-4011

News Archive

Adding a commonly used dietary supplement to antidepressants may improve treatment

Massachusetts General Hospital (MGH) researchers have found that adding the nutritional supplement SAMe to a standard antidepressant may be helpful to patients who have not responded to single-drug treatment for clinical depression.

Calif. Gov. Schwarzenegger plans health cuts; news outlets report on Medicaid funding issues

California Gov. Arnold Schwarzenegger is planning cuts to health programs and has "warned more would come if the federal government does not increase program reimbursements," ModernHealthcare reports. "His $82.9 billion spending plan for fiscal 2010-11 includes $750 million in cuts to Medi-Cal, the state's Medicaid program. Prison medical care would be cut by $811 million under his plan." Schwarzenegger is seeking $1.8 billion more in Medicaid funds by raising California's match to the national average for the program — 57 percent (Vesely, 1/8).

Affordable Care Act may alter costs for Automobile and liability insurance

The expansion of health insurance accomplished under the Affordable Care Act may alter costs for several major types of liability insurance, although any such changes are likely to be modest, according to a new RAND Corporation report.

Dana-Farber/Boston Children's joins immunotherapy clinical trial for children with ALL

Dana-Farber/Boston Children's Cancer and Blood Disorders Center has joined a clinical trial of immunotherapy for children with relapsed or treatment-resistant acute lymphoblastic leukemia (ALL). Led by Memorial Sloan Kettering Cancer Center, the trial is one of several nationally that are evaluating cancer immunotherapy, a treatment approach - hailed by Science magazine as their Breakthrough of the Year in 2013 - that triggers a patient's immune system to attack his or her cancer cells.

Read more Medical News

› Verified 3 days ago